Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
The Perth Blood Institute Limited
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • Who we are
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
      • Thrombosis Australia Advisory Panel
    • Work with us
  • Our clinical trials
    • Clinical trials
    • Collaborations
    • Participate in a clinical trial
    • Useful links
  • Our research
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Blood disorders
      • Anaemia
      • Antiphospholipid syndrome (APS)
      • Haemophilia
      • Polycythemia vera
      • Thrombocythaemia
      • Thrombophilia
      • TTP
      • von Willebrand Disease
    • Blood cancers
      • Myelofibrosis (MF)
      • Chronic lymphocytic leukaemia
      • Lymphoma
    • For patients and families
  • Personal stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Partner with us
    • Leave a gift in your will
    • Other ways to help
  • News and events
    • Latest news & info
    • Previous news
    • 10 Year Anniversary
    • Significant days
      • 2023
      • 2022
    • Media
    • Upcoming events
    • Publications
  • COVID-19
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)
  • Anaemia Fact Sheet

Anaemia Fact Sheet

Red blood cells (RBC) contain haemoglobin (HGB), a protein that enables oxygen to be carried from the lungs to the body. When the number of RBCs is reduced, or they are not healthy, the blood cannot carry a sufficient amount of oxygen. An inadequate supply of oxygen in the tissues causes the symptoms associated with anaemia.

Prevalence

Anaemia is a serious global health concern, predominantly affecting children and pregnant women. The World Health Organization (WHO) estimates that 42% of children under age 5 and 40% of pregnant women around the world suffer from anaemia. In 2021, data showed that the prevalence was 31.2% for women and 17.5% for males.

Data collected between 1993-2005 from the WHO Vitamin and Mineral Nutrition Information System found that an estimated global prevalence of anaemia was 24.8% (1.62 billion people). Results from previous and current Global Burden of Disease Studies found that there were 1.5 billion anaemic people worldwide in 1990, 1.8 billion in 2019, and 1.92 billion in 2021.

Symptoms

Signs and symptoms can vary depending on the cause and severity of the anaemia, and may include the following:

  • Fatigue, tired.
  • Unexplained weakness.
  • Pale or yellowish skin.
  • Irregular heartbeats.
  • Shortness of breath.
  • Dizziness or light-headedness.
  • Chest pain.
  • Cold hands and feet.
  • Headaches.

Causes

  • Congenital (present at birth).
  • Hereditary.
  • Acquired.
  • The body does not make enough RBCs.
  • Bleeding – lose RBCs more quickly than they can be replaced.
  • The body destroys RBCs.

Risk factors

The following can increase the risk of anaemia:

  • A diet low in iron, vitamin B-12, folate and copper. 
  • Having an intestinal disorder (e.g., Crohn’s or celiac disease) affects nutrient absorption. 
  • Menstruating women have a higher risk of iron deficiency and a loss of RBCs.
  • Pregnant women and women not taking folic acid and iron supplementation.
  • Chronic conditions such as cancer can lead to a shortage of RBCs.
  • Slow blood loss within the body (e.g., from an ulcer) can deplete the body of iron.
  • Family history.
  • Infections, blood diseases and autoimmune disorders.
  • People aged over 65 years.

Types of anaemia

Anaemia can be temporary or long term; mild or severe.

Iron deficiency anaemia – this common type of anaemia is when the body lacks appropriate levels or iron. Iron is needed to produce sufficient levels of haemoglobin to carry oxygen around the body. Symptoms include tiredness and shortness of breath.

Vitamin deficiency anaemia – the body lacks healthy RBCs caused by a reduction in vitamin B-12 and folate. Without sufficient levels of these nutrients, the body produces RBCs which are too large and do not work properly; therefore, reducing their ability to carry oxygen. Symptoms include fatigue, SOB and dizziness.

Aplastic anaemia – when the body stops producing enough new blood cells and can lead to uncontrolled bleeding and an increased risk of infections. This condition is rare and serious and can develop at any age; develop suddenly or over time. In addition to the above symptoms, further signs or symptoms may present – aplastic anaemia can have unexplained or easy bruising; nosebleeds, bleeding gums, and prolonged bleeding from cuts; skin rash; and fever.

Thalassemia – this is an inherited blood disorder which causes the body to have less haemoglobin than normal. Mild thalassemia may not require treatment however, severe forms might involve ongoing blood transfusions. In addition to the above symptoms, other signs or symptoms may appear – facial bone deformities; slow growth; abnormal swelling; and dark urine.

Low haemoglobin and cognitive health

As mentioned above, HGB is an important factor involved in transporting oxygen around the body. Research has shown that there is a link between anaemia and dementia among the elderly, however the mechanisms involved are not well known. Below are the findings from recent studies which showed that low haemoglobin levels and anaemia are associated with lower cognitive health, Dementia and Alzheimer’s disease.

Summary of research findings:

Associations of blood cell indices and anemia with risk of incident dementia, 2023

  • Decreased levels of RBC and HGB are indicative of anaemia, and were associated with higher dementia incidence.
  • Red blood cell distribution width (RDW) was a sign of the assortment of RBCs which was positively related to dementia risk.
  • When the World Health Organization’s criteria for anaemia was applied, individuals with anaemia showed a 56% higher risk of dementia compared to those who were not anaemic.
  • Results also showed that the risk was increased despite the cause of anaemia – deficiencies in nutrients (iron, Vitamin B12 or folate).

The impact of low haemoglobin levels on cognitive brain functions, 2020

  • Hypoxia (or hypoxemia) is a low level of oxygen in the blood and can be caused by anaemia and be a mechanism responsible for dementia.
  • Anaemia leads to a rise in the risk of dementia by 34% and Alzheimer’s disease by 41%.
  • One theory is that low HGB could cause chronic hypoxia of brain cells which cause inflammation of neurons which can cause a decline in brain functions. The brain reacts to the anaemia by dilating the blood vessels (vasodilation) which causes the brain to increase blood flow to try to compensate for the reduction in HGB. However, this adjustment fails and blood flow to the cerebral cortex becomes insufficient, leading to neurological deficiency.
  • Another theory is associated with erythropoietin (EPO - hormone which stimulates RBC production in response to hypoxia) receptors in the brain. EPO acts as neuroprotective against hypoxia, therefore low EPO levels may induce the risk of neuronal damage and cognitive decline.

Further clinical studies are recommended to determine the exact association between low HGB levels and decreased cognitive brain functions. However, these studies show the possible link with anaemia and dementia which demonstes the necessity for research into establishing preventative screening tests.

Haemoglobin levels and pregnancy

Anaemia during pregnancy is commonly due to iron or folate deficiency. However, another mechanism during pregnancy also plays a role. At the beginning of pregnancy, plasma volume and haemoglobin levels increase, with the plasma levels rising disproportionately at about the sixth week. This affects haemoglobin levels, causing them to decline, producing anaemia.

Anaemia during pregnancy is correlated to an increased risk of caesarean section, maternal mortality and adverse consequences such as preterm birth, small for gestational age (SGA), and perinatal and neonatal mortality. Research suggests a link between maternal haemoglobin levels and these outcomes.

At the beginning of pregnancy, plasma volume and haemoglobin levels increase, however at about the sixth week point, the plasma levels rise disproportionately. This affects haemoglobin levels, causing them to decline, producing anaemia.

During pregnancy, a haemoglobin level of <110g/L in the first trimester and <105 or 110g/L in the second and third trimester is classed has having anaemia. The WHO also base anaemia on a haemoglobin threshold of <110g/L. The CDC and WHO have established specific cutoffs for maternal anaemia; <110g/L for first and third trimester and 105g/L for the second trimester. Maternal mortality was twice as high in women with severe anaemia compared to those without. Severe anaemia is defined as haemoglobin concentrations less than 70g/L.

Hypoxia (inadequate oxygen supply to organs and tissues) can be the result of being anaemic. Studies believe hypoxia of the placenta may be associated to pregnancy complications such as pre-eclampsia, intrauterine growth restriction and SGA. The theory is that both anaemia and elevated haemoglobin scores throughout pregnancy may lead to a suboptimal oxygen supply and reduced nutrients being delivered to the placenta and foetus. Therefore, haemoglobin cutoff levels may be associated with a decreased risk of adverse maternal and neonatal outcomes.


References

  • Overview of Anemia - Blood Disorders - Merck Manuals Consumer Version
  • Anemia - Symptoms and causes - Mayo Clinic
  • Low blood oxygen (hypoxemia) - Mayo Clinic
  • Anaemia (who.int)
  • Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005 - PubMed (nih.gov)
  • Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019 | Journal of Hematology & Oncology | Full Text (biomedcentral.com)
  • Gattas, B.S., Ibetoh, C.N., Stratulat, E., Liu, F., Wuni, G.Y., Bahuva, R., Shafiq, M.A., & Gordon, D.K. (2020). The impact of low hemoglobin levels on cognitive brain functions. Cureus. 8;12(11):e11378. doi: 10.7759/cureus.11378.
  • Qiang, Yi-Xuan et al. (2023). Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 Participants. Alzheimer’s & dementia.
  • James, A. (2021). Iron deficiency anemia in pregnancy. Obstetrics & Gynecology, 138(4), 663-674. doi:10:10.1097/AOG.0000000000004559.
  • Ohuma, E.O., Jabin, N., Young, M.FL., Epie, T., Martorell, R., Peña-Ross, J.P., & Garcia-Casal, M.N. (2023), Association between maternal haemoglobin concentrations and maternal and neonatal outcomes: the prospective, observational, multinational, INTERBIO-21st fetal study. Lancet Haematol. S2352-3026(23)0017-9. Doi:10.1016/S2352-3026(23)00170-9.
  • GBD 2021 Anaemia Collaborators. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021. The Lancet Haematology. 31 July 2023. doi: 10.1016/ S2352-3026(23)00160-6.

Published: 4th April, 2023

Updated: 7th December, 2023

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Atrial fibrillation - Research 2021-2022

  • CAT - Research 2021-2022

  • Iron Deficiency Day 2023

    Iron Deficiency Day 2023

    World Iron Deficiency Day on the 26th of November provides an opportunity to emphasise the importance and significance of this universal health condition.

  • World Stroke Day 2023

    World Stroke Day 2023

    Stroke is the second leading cause of death worldwide with millions of people affected every year. October 29 is World Stroke Day and provides an opportunity to remind everyone how important healthy blood vessels are and reduce the risk of stroke.

Related

  • Thrombocythaemia

    Thrombocythaemia

    Thrombocythaemia and thrombocytosis are blood disorders involving platelets, which can cause blood clots and bleeding.

  • Polycythemia vera

    Polycythemia vera

    Polycythemia vera is a rare type of blood cancer known as a ‘myeloproliferative disorder’ which refers to when bone marrow produces blood cells in a rapid and uncontrolled way.

  • Antiphospholipid syndrome (APS)

    Antiphospholipid syndrome (APS)

    Antiphospholipid syndrome (APS) is a rare acquired pre-thrombotic autoimmune disease. Here we provide some information regarding the condition.

  • von Willebrand Disease (VWD)

    VWD is an inherited bleeding disorder and is one of the most common bleeding disorders worldwide. Here we provide some background information about the disease.

  • Haemophilia

    Haemophilia

    Haemophilia is a X-linked blood disorder which is estimated to affect 400,000 persons globally. Here we provide some information about Haemophilia A and B.

  • Thrombophilia

    Thrombophilia

    Thrombophilia is an abnormal coagulation process which can be inherited or acquired. It results in a hypercoagulable state and increases the risk of thrombotic events where blood clots can form in either the arteries or veins.

  • TTP (Thrombotic Thrombocytopenic Purpura)

    TTP (Thrombotic Thrombocytopenic Purpura)

    TTP is a rare life-threatening blood disorder with an annual incidence of 3 to 11 cases per million people. Here is a review of the condition.

Most read

  • What is thrombosis?

    What is thrombosis?

    Click here to learn more about thrombosis.

  • What are DVT & PE?

    What are DVT & PE?

    Click here to learn more about DVT and PE.

  • Work and Thrombosis

    Work and Thrombosis

    Click here to learn more about how work can increase your risk of thrombosis, and how to prevent it.

  • Travel and Thrombosis

    Travel and Thrombosis

    Click here to learn about how travel can increase your risk of developing dangerous blood clots.

  • Contraception and Thrombosis

    Contraception and Thrombosis

    Click here to learn more about how certain contraceptives can increase your risk of dangerous blood clots.

  • Antiphospholipid Antibody Syndrome

    Antiphospholipid Antibody Syndrome

    Click here for information about antiphospholipid antibody syndrome and how it can lead to thrombosis.

  • Inherited Thrombophilias

    Inherited Thrombophilias

    Click here for information about genetic conditions that can increase the chances of thrombosis.

  • Investigators

    Investigators

  • PCOS and thrombosis

    PCOS and thrombosis

    Polycystic Ovary Syndrome (PCOS) is a hormonal disorder and one of the most common endocrine system and reproductive disorders among women. Here we provide some information regarding its association with thrombosis.

  • Participate in a clinical trial

    Participate in a clinical trial

    PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers.

Tag cloud

Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA
Donate today

Donate today

Please help to make blood disorders a thing of the past. Every amount is vital to our research, no matter how large or small. Read more

Donate Fundraise

Published: 18th February, 2020

Updated: 8th May, 2023

Author:

SUPERNOVA clinical trial

SUPERNOVA clinical trial

Perth Blood Institute (PBI) start new Australian-wide clinical trial – SUPERNOVA Read more

Published: 3rd July, 2023

Updated: 2nd August, 2023

Author: Gina Rodgers

Comments: 1

PBI celebrates 10 Year Anniversary!

PBI celebrates 10 Year Anniversary!

"It is with your support that we have continued to grow over the past 10 years – to continue to advance medical discoveries and improve care for patients. " Professor Ross Baker Read more

Published: 4th July, 2023

Updated: 21st September, 2023

Author: Bec Morgan

Graham Wild

Graham Wild

Graham Wild, a passionate 15-year-old boy with a deep love for nature and animals, had dreams of running an animal sanctuary. After returning from a trip to see his dad, Graham started to have trouble breathing and his health rapidly deteriorated. Despite urgent medical attention, his heart stopped, and he couldn't be revived. Graham's mother Kathryn would like to share his story. Read more

Published: 13th July, 2023

Updated: 14th September, 2023

Author: Jacqui Le

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020